Top Markets
Coin of the day
Zoetis Inc. Zoetis Inc.

Zoetis Inc.

ZTS
Rang in Aktien #827
Zoetis Inc. stands as a global leader in animal health, focusing on the... Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents. This includes vaccines, vital for preventing respiratory, gastrointestinal, and reproductive diseases by stimulating a targeted immune response; anti-infectives that combat or inhibit the proliferation of bacterial, fungal, or protozoal pathogens; and parasiticides aimed at eradicating both internal and external pests such as fleas, ticks, and various worms. Additional pharmaceuticals address areas such as pain management and sedation, anti-emesis, reproductive health, and oncology. The portfolio also features dermatological solutions for allergic skin conditions and atopic dermatitis, alongside medicated feed additives specifically designed for livestock. Beyond therapeutics, Zoetis offers an extensive array of diagnostic solutions. These include portable analysis systems for blood and urine, point-of-care testing devices, specialized instruments and reagents, rapid immunoassay kits, comprehensive reference laboratory services, and blood glucose monitoring equipment. Further extending its reach, the company provides supplementary offerings such as nutritional products, agribusiness support services, biodevices, genetic testing, and innovations in precision animal health. Zoetis distributes its diverse product portfolio to a broad customer base, including veterinary professionals, livestock producers, and retail channels. This distribution occurs directly via its sales representatives and technical specialists, as well as through partnerships with third-party veterinary distributors. Established in 1952, the company maintains its corporate headquarters in Parsippany, New Jersey.
Aktienkurs
$71.46
Marktkapitalisierung
$29.96B
Veränderung (1 Tag)
-0.04%
Veränderung (1 Jahr)
-51.01%
Land
US
Handel Zoetis Inc. (ZTS)

Kategorie

EPS für Zoetis Inc. (ZTS)
EPS zum June 2026 TTM: $6.08
Laut den aktuellen Finanzberichten und dem Aktienkurs von Zoetis Inc. beträgt das aktuelle EPS des Unternehmens (TTM) $6.08. Am Ende des Jahres 2024 betrug das EPS $5.47 eine Steigerung gegenüber dem EPS von 2023, das $5.08 betrug.
EPS-Verlauf von Zoetis Inc. von 2009 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
2026 (TTM) $6.08 0.83%
2025 $6.03 10.24%
2024 $5.47 7.68%
2023 $5.08 12.64%
2022 $4.51 5.13%
2021 $4.29 24.71%
2020 $3.44 9.55%
2019 $3.14 6.08%
2018 $2.96 68.18%
2017 $1.76 6.02%
2016 $1.66 144.12%
2015 $0.68 -41.38%
2014 $1.16 14.85%
2013 $1.01 16.09%
2012 $0.87 70.59%
2011 $0.51 121.74%
2010 $0.23 -209.52%
2009 $-0.21 0.00%
EPS für ähnliche Unternehmen oder Wettbewerber
Unternehmen EPS EPS-Differenz Land
$29.85 390.95%
US
$8.65 42.27%
US
$3.55 -41.61%
US
$20.39 235.35%
CH
$1.26 -79.28%
US